Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | GNAI3 | P08754 | 1/20 | 0.64 |
| ▸ | GNAO1 | P09471 | 1/20 | 0.64 |
| ▸ | GNAI1 | P63096 | 1/20 | 0.64 |
| ▸ | DPP7 | Q9UHL4 | 2/20 | 0.51 |
| ▸ | DPP8 | Q6V1X1 | 1/20 | 0.51 |
| ▸ | DPP9 | Q86TI2 | 1/20 | 0.51 |
| ▸ | GSR | P00390 | 1/20 | 0.50 |
| ▸ | RRM1 | P23921 | 1/20 | 0.50 |
| ▸ | TLR2 | O60603 | 2/20 | 0.49 |
| ▸ | CES2 | O00748 | 1/20 | 0.48 |
| ▸ | MEN1 | O00255 | 1/20 | 0.48 |
| ▸ | TP53 | P04637 | 1/20 | 0.48 |
| ▸ | CYP1A2 | P05177 | 1/20 | 0.48 |
| ▸ | CYP2D6 | P10635 | 1/20 | 0.48 |
| ▸ | MAPT | P10636 | 1/20 | 0.48 |
| ▸ | CYP2C9 | P11712 | 1/20 | 0.48 |
| ▸ | CYP2C19 | P33261 | 1/20 | 0.48 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.48 |
| ▸ | CHRM2 | P08172 | 1/20 | 0.47 |
| ▸ | CHRM4 | P08173 | 1/20 | 0.47 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL6271110 | 1.00 | GNAI3 (0.64) | GNAI3GNAO1GNAI1DPP7DPP8 | |
| SCHEMBL25469804 | 0.95 | GNAI3 (0.57) | GNAI3GNAO1GNAI1DPP7DPP8 | |
| SCHEMBL14154835 | 0.93 | GNAI3 (0.58) | GNAI3GNAO1GNAI1DPP7DPP8 | |
| SCHEMBL19114834 | 0.93 | GNAI3 (0.58) | GNAI3GNAO1GNAI1DPP7DPP8 | |
| SCHEMBL904746 | 0.93 | CES2 (0.55) | GNAI3GNAO1GNAI1DPP7CES2 | |
| SCHEMBL17374802 | 0.93 | CES2 (0.55) | GNAI3GNAO1GNAI1DPP7CES2 | |
| SCHEMBL27752426 | 0.93 | CES2 (0.55) | GNAI3GNAO1GNAI1DPP7CES2 | |
| SCHEMBL11395919 | 0.93 | CES2 (0.55) | GNAI3GNAO1GNAI1DPP7CES2 | |
| SCHEMBL17029472 | 0.91 | GSR (0.59) | GNAI3GNAO1GNAI1DPP7DPP8 | |
| SCHEMBL32676262 | 0.91 | DPP7 (0.53) | GNAI3GNAO1GNAI1DPP7CES2 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20260048130-A1 | ALPHA-V BETA-6 (avb6) INTEGRIN LIGANDS FOR EXTRAHEPATIC DELIVERY | ALNYLAM PHARMACEUTICALS INC (US) | 2026-02-19 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20260048130-A1 | ALPHA-V BETA-6 (avb6) INTEGRIN LIGANDS FOR EXTRAHEPATIC DELIVERY | ITGB6, ITGA6, ITGA2B | GNAI3 1144/4885GNAO1 1202/4885GNAI1 992/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.